Abstract
Constrained acetabular components are a useful adjunct for the potentially unstable hip arthroplasty. There have been concerns over implant failure and early acetabular component loosening secondary to the increased implant constraint. We report the results of a constrained ace-tabular component used as treatment for dislocating hips and as prophylaxis against dislocation in high risk primary and revision hip arthroplasty. At average 3.1 years follow-up only one insert of eighty-nine inserted had failed. No cups have demonstrated radiographic or clinical evidence of loosening. We conclude this implant is safe and effective for both the prevention and treatment of hip instability.
To review the effectiveness and durability of a constrained acetabular component used to treat and prevent recurrent dislocation after total hip arthroplasty
Constrained acetabular components of this type provide both an excellent treatment and preventative option in total hip arthroplasty. There is no evidence of accelerated cup loosening and the implant failure rate remains acceptable despite the increased constraint.
Constrained acetabular components have been mainly used as a salvage option for dislocating hip arthroplasty. There have been concerns over implant failure and early acetabular component loosening secondary to the increased implant constraint. Use of this implant can prevent dislocation in high risk patient groups (eg: revision surgery) without compromising implant longevity. This significantly reduces the potential morbidity associated with hip instability.
Eighty-nine patients received the tripolar constrained acetabular component. Fifteen were inserted for recurrent dislocation whilst seventy-two were inserted in patients felt to be at high risk of dislocation (forty-nine for intra-operative instability at revision surgery, twenty-five for primary THA in patients with poor compliance, neurological conditions or deficient abductor mechanism). One implant failed by component dissociation at eighteen months. All other recurrent dislocators remained stable. There was no evidence of accelerated component loosening at medium term review (range twelve – eighty three months, average thirty-seven months)
Radiographic and clinical data was prospectively collected on eighty-nine patients who had the constrained acetabular component inserted.
Funding: The primary author’s fellowship position is partially funded by Smith and Nephew Richards Inc.
Correspondence should be addressed to Cynthia Vezina, Communications Manager, COA, 4150-360 Ste. Catherine St. West, Westmount, QC H3Z 2Y5, Canada